U.S. Securities and Exchange Commissionregulator
DevelopingETF

Injective founder says a US spot INJ ETF could arrive before 2027

Eric Chen told The Block a 2027 start for a US spot INJ ETF is too far off, while 21Shares and Canary Capital applications sit with the SEC.

Why it matters

Two live ETF filings for INJ put the token in front of US regulators, and a staking feature in Canary's filing would widen the set of crypto assets eligible for exchange-traded products. Injective's transfer agent registration and MiCA technical document work extend its regulatory groundwork in the US and Europe. Only one outlet has reported Chen's comments, so the timeline remains unconfirmed.

Key facts

Eric Chen told The Block that2027 is a bit too far off for a US spot INJ ETF to start trading.

Reported by Crypto News (CryptoNews.net)

Two ETF applications for INJ are pending with the US SEC: the 21Shares Injective ETF and the Canary Staked INJ ETF, which includes staking.

Reported by Crypto News (CryptoNews.net)

21Shares filed Form S-1/A with the SEC in September 2026, stating the fund's primary objective is to track the price performance of INJ and that it plans to list on Nasdaq.

Reported by Crypto News (CryptoNews.net)

Canary Capital submitted its initial application for a staking-enabled INJ ETF in the US in 2025.

Reported by Crypto News (CryptoNews.net)

Injective Institutional Services became an SEC-registered transfer agent in August.

Reported by Crypto News (CryptoNews.net)

Injective completed the notification and publication process for INJ's MiCA technical document in July.

Reported by Crypto News (CryptoNews.net)

What happened

Speaking to The Block, Injective founder Eric Chen declined to name a date for a US spot INJ ETF but said 2027 is a bit too far off, indicating a launch could come sooner. Two applications are pending at the US SEC: the 21Shares Injective ETF, which filed an amended Form S-1/A in September 2026 and says it will track INJ and list on Nasdaq, and the Canary Staked INJ ETF, which adds staking and was first submitted by Canary Capital in 2025. Chen said Injective is working toward more licenses after Injective Institutional Services became an SEC-registered transfer agent in August. He added that Injective finished the notification and publication process for INJ's MiCA technical document in July. Crypto News, the only outlet in this set carrying the story, reported Chen's comments; the SEC has not published any decision on either filing in the material available.

How the story developed

  1. First report

    First report by Crypto News (CryptoNews.net)

    Another Altcoin on the Path to an ETF! Founder Gives a Date: All Eyes on the SEC!

    Crypto News (CryptoNews.net)

  2. Update

    Canary Capital files first US INJ ETF application

    The staking-enabled filing marks the earliest of the two pending applications.

    Crypto News (CryptoNews.net)

  3. Official statement

    21Shares amends filing with SEC

    Form S-1/A states the fund tracks INJ and plans a Nasdaq listing.

    Crypto News (CryptoNews.net)

  4. Official statement

    Injective Institutional Services registers as SEC transfer agent

    Chen said the registration is the start of a push for further licences.

    Crypto News (CryptoNews.net)

  5. Update

    Chen signals INJ ETF could come sooner than 2027

    He declined to give a precise date but said 2027 is too far off.

    Crypto News (CryptoNews.net)

  6. Official statement

    Injective finishes MiCA technical document process

    Chen said the notification and publication process for INJ's MiCA document was completed in July.

    Crypto News (CryptoNews.net)

Affected entities

Original sources

PublisherReportRolePublished
Crypto News (CryptoNews.net)
Aggregator
Another Altcoin on the Path to an ETF! Founder Gives a Date: All Eyes on the SEC!Original
Injective founder says a US spot INJ ETF could arrive before 2027 — Crypto News Intelligence